Panorama de portfólio de vacinas em desenvolvimento

Os dados são atualizados semanalmente, das seguintes fontes:

WHO – https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines

London School of Hygiene & Tropical Medicine – https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker

Busque por termos

Selecione ao lado o filtro desejado:

Últimos 30 registros

Abaixo os últimos 30 registros encontrados em nossa base de dados.

Digite um termo acima para filtrar sua busca na tabela abaixo.

Candidato Patrocínio Fase de testes Instituição Data
Inactivated vaccineWuhan Institute of Biological Products; China National Pharmaceutical Group (Sinopharm)Phase 3Henan Provincial Center for Disease Control and Prevention2020-09-08
CoronaVac - APROVADA (CHINA)SinovacPhase 3Sinovac Research and Development Co., Ltd.2020-09-08
mRNA-1273ModernaPhase 3Kaiser Permanente Washington Health Research Institute2020-09-08
Ad5-nCoVCanSino BiologicsPhase 3Tongji Hospital; Wuhan, China2020-09-08
Bacillus Calmette-Guerin (BCG) live-attenuated vaccineUniversity of Melbourne and Murdoch Children’s Research InstituteRadboud University Medical CenterFaustman Lab at Massachusetts General HospitalPhase 2/3University of Melbourne and Murdoch Children’s Research InstituteRadboud University Medical CenterFaustman Lab at Massachusetts General Hospital2020-09-08
AZD1222/CovishieldThe University of Oxford; AstraZeneca; IQVIA; Serum Institute of IndiaPhase 3The University of Oxfordthe Jenner Institute2020-09-08
BNT162 - APROVADA (UK, Bahrain, Canada)Pfizer, BioNTech< APROVADA/a>Phase 2/3Multiple study sites in Europe and North America2020-09-08
NVX-CoV2373NovavaxPhase 2bNovavax2020-09-08
Adjuvant recombinant vaccine candidateAnhui Zhifei Longcom Biopharmaceutical, Institute of Microbiology of the Chinese Academy of SciencesPhase 22020-09-08
ZyCoV-DZydus CadilaPhase 2Zydus Cadila2020-09-08
CovaxinBharat Biotech; National Institute of VirologyPhase 22020-09-08
BBIBP-CorV - APROVADA (China, United Arab Emirates)Beijing Institute of Biological Products; China National Pharmaceutical Group (Sinopharm) - APROVADA Phase 1/2Henan Provincial Center for Disease Control and Prevention2020-09-08
GX-19GenexinePhase 1/22020-09-08
Sputnik V - APROVADA (RUSSIA)Gamaleya Research Institute, Acellena Contract Drug Research and DevelopmentPhase 1/2Various2020-09-08
Self-amplifying RNA vaccineImperial College LondonPhase 1/2Imperial College London2020-09-08
LUNAR-COV19Arcturus Therapeutics and Duke-NUS Medical SchoolPhase 1/2Duke-NUS Medical School, Singapore2020-09-08
INO-4800Inovio PharmaceuticalsPhase 1/2Center for Pharmaceutical Research, Kansas City. Mo.; University of Pennsylvania, Philadelphia2020-09-08
CVnCoVCureVacPhase 1CureVac2020-09-08
SCB-2019GlaxoSmithKlineSanofiClover Biopharmaceuticals, Dynavax and Xiamen InnovaxPhase 1Linear Clinical Research (Australia)2020-09-08
COVAX-19Vaxine Pty Ltd.Phase 1Royal Adelaide Hospital2020-09-08
Plant-based adjutant COVID-19 vaccine candidate Medicago; GSK; DynavaxPhase 1Medicago2020-09-08
Molecular clamp vaccineCSL; The University of QueenslandPhase 12020-09-08
V590Merck; IAVIPhase 12020-09-08
GRAd-COV2ReiTheraLeukocareUnivercellsPhase 1Lazzaro Spallanzani National Institute for Infectious Diseases2020-09-08
bacTRL-SpikeSymvivoPre-clinicalSymvivo Corporation2020-09-08
PittCoVaccUPMC/University of Pittsburgh School of MedicinePre-clinicalUniversity of Pittsburgh2020-09-08
V591University of Pittsburgh’s Center for Vaccine ResearchPhase 1University of Pittsburgh; Themis Biosciences; Institut Pasteur2020-09-08
Ii-Key peptide COVID-19 vaccineGenerex BiotechnologyPre-clinicalGenerex2020-09-08
Recombinant vaccineVaxartPre-clinicalVaxart2020-09-08
LineaDNATakis BiotechPre-clinicalTakis Biotech2020-09-08
Acompanhe conosco os principais dados de covid do Brasil
https://covid.saude.gov.br/

Painel de casos de doença pelo coronavírus 2019 (COVID-19) no Brasil pelo Ministério da Saúde. Diariamente, o Ministério da Saúde, por meio da Secretaria de Vigilância em Saúde (SVS/MS) divulga dados consolidados sobre o COVID-19. Saiba mais sobre o painel.

https://bigdata-covid19.icict.fiocruz.br/

Este projeto utiliza recursos computacionais e cientistas de dados da Plataforma de Ciência de Dados aplicada à Saúde do Laboratório de Informação em Saúde do Icict da Fiocruz (PCDaS), hospedada no Laboratório Nacional de Computação Científica (LNCC).

Campus Sede:

Av. Brasil, 4365 – Manguinhos, Rio de Janeiro – CEP: 21040-900 – Tel: (0xx21) 2598-4242

Este portal é regido pela Política de Acesso Aberto ao Conhecimento, que busca garantir à sociedade o acesso gratuito, público e aberto ao conteúdo integral de toda obra intelectual produzida pela Fiocruz.

© COPYRIGHT / Todos os direitos reservados ao Laboratório de Informação Científica e Tecnológica em Saúde – LICTS / FIOCRUZ